Neurogene
NGNE
NGNE
84 hedge funds and large institutions have $193M invested in Neurogene in 2025 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 29 increasing their positions, 24 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
48% less capital invested
Capital invested by funds: $368M → $193M (-$175M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
59% less call options, than puts
Call options by funds: $1.19M | Put options by funds: $2.93M
Holders
84
Holding in Top 10
1
Calls
$1.19M
Puts
$2.93M
Top Buyers
| 1 | +$9.51M | |
| 2 | +$2.8M | |
| 3 | +$1.85M | |
| 4 |
CC
Commodore Capital
New York
|
+$1.46M |
| 5 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
+$1.37M |
Top Sellers
| 1 | -$4.65M | |
| 2 | -$4.61M | |
| 3 | -$2.82M | |
| 4 |
VPC
Vestal Point Capital
New York
|
-$1.83M |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$1.62M |